Shanghai Kinetic Medical Co., Ltd. Class A

Shanghai Kinetic Medical Co., Ltd. Class A

SSZSE:300326
6.37
CNY
-0.07
(-1.09%)
0.36EPS
16.59P/E
4.46BMarket Cap
Apr 26Next Earn

Total Valuation

CNY

As of September 30, 2026, Shanghai Kinetic Medical Co., Ltd. Class A carries a market capitalization of 4.46B, placing it among publicly traded companies globally. Its enterprise value stands at 2.86B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap4.46B
Enterprise Value2.86B

Important Dates

Shanghai Kinetic Medical Co., Ltd. Class A's next confirmed earnings release is scheduled for April 26, 2027.

Earnings Date4/26/2027

Share Statistics

As of September 30, 2026, Shanghai Kinetic Medical Co., Ltd. Class A has 717.01M shares outstanding.

Shares Outstanding717.01M

Valuation Ratios

As of September 30, 2026, Shanghai Kinetic Medical Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 16.59. The price-to-sales ratio is 6.08, and the price-to-book ratio stands at 1.50.

PE Ratio16.59
PS Ratio6.08
PB Ratio1.50
P/TBV Ratio1.90

Enterprise Valuation

As of September 30, 2026, Shanghai Kinetic Medical Co., Ltd. Class A trades at an EV/EBITDA multiple of 10.75 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.89 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 10.75 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 2.86B versus a market cap of 4.46B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales3.89
EV / EBITDA10.75
EV / EBIT10.75

Financial Position

As of September 30, 2026, Shanghai Kinetic Medical Co., Ltd. Class A maintains a current ratio of 14.41, meaning it holds 14.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.68, indicating elevated leverage, while an interest coverage ratio of 291.98 demonstrates strong ability to service its debt obligations.

Current Ratio14.41
Quick Ratio11.41
Debt / Equity1.68
Debt / EBITDA0.19
Interest Coverage291.98

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Shanghai Kinetic Medical Co., Ltd. Class A posted a return on equity (ROE) of 9.38, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 8.14 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 8.25, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 8.99, useful for judging operating efficiency across full business cycles. The company generates approximately 1.33M in revenue per employee across its workforce of 553.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.73 indicates how many times Shanghai Kinetic Medical Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)9.38
Return on Assets (ROA)8.25
Return on Invested Capital (ROIC)8.14
Return on Capital Employed (ROCE)8.99
Revenue Per Employee1.33M
Employee Count553.00
Inventory Turnover0.73

Taxes

CNY

Over the twelve months ended September 30, 2026, Shanghai Kinetic Medical Co., Ltd. Class A recorded 11.99M in income tax expense. That works out to an effective tax rate of 4.42, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 270.99M, leaving 268.88M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax11.99M
Effective Tax Rate4.42

Stock Price Statistics

CNY

As of the close on November 17, 2026, Shanghai Kinetic Medical Co., Ltd. Class A's stock has gained approximately 4.94% over the past 52 weeks. The 50-day moving average sits at 6.35, while the 200-day moving average is 6.28.

52-Week Price Change4.94%
50-Day Moving Average6.35
200-Day Moving Average6.28

Income Statement

CNY

Over the twelve months ended September 30, 2026, Shanghai Kinetic Medical Co., Ltd. Class A generated 734.04M in revenue and converted that into 268.88M in net income, yielding earnings per share of 0.36. EBITDA reached 265.73M, while operating income came in at 171.84M.

Revenue734.04M
Gross Profit492.17M
Operating Income171.84M
Pretax Income270.99M
Net Income268.88M
EBITDA265.73M
EBIT265.73M
Earnings Per Share (EPS)0.36

Balance Sheet

CNY

As of September 30, 2026, Shanghai Kinetic Medical Co., Ltd. Class A holds 1.68B in cash and equivalents against 50.34M in total debt, resulting in a net debt position of -396.14M. Total book value stands at 2.97B, with working capital of 1.98B providing operational flexibility.

Cash & Cash Equivalents1.68B
Total Debt50.34M
Net Debt-396.14M
Equity (Book Value)2.97B
Book Value Per Share4.14
Working Capital1.98B

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-21.75M

Margins

Over the twelve months ended September 30, 2026, Shanghai Kinetic Medical Co., Ltd. Class A posted a gross margin of 67.05, reflecting its pricing power and cost economics. The operating margin of 23.41 and net profit margin of 36.63 provide insight into operational efficiency.

Gross Margin67.05
Operating Margin23.41
Pretax Margin36.92
Profit Margin36.63
EBITDA Margin36.20

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Shanghai Kinetic Medical Co., Ltd. Class A paid dividends of 0.10 per share. The dividend payout ratio of 29.20 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 1.81, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Shanghai Kinetic Medical Co., Ltd. Class A shareholders.

Dividend Per Share0.10
Payout Ratio29.20
Shareholder Yield1.81

Stock Splits

Shanghai Kinetic Medical Co., Ltd. Class A's most recent stock split took place on October 21, 2016 with a 427:766 split ratio.

Last Split Date10/21/2016
Split Ratio427:766

Scores

As of September 30, 2026, Shanghai Kinetic Medical Co., Ltd. Class A has an Altman Z-Score of 18.04, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score18.04